These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1925722)

  • 1. Erythromycin ototoxicity: a call to heighten recognition.
    Whitener CJ; Parker JE; Lapp NL
    South Med J; 1991 Oct; 84(10):1214-6. PubMed ID: 1925722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxic reaction to erythromycin.
    Agustí C; Ferrán F; Gea J; Picado C
    Arch Intern Med; 1991 Feb; 151(2):380. PubMed ID: 1992966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction.
    Umstead GS; Neumann KH
    Arch Intern Med; 1986 May; 146(5):897-9. PubMed ID: 3963982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate.
    Karmody CS; Weinstein L
    Ann Otol Rhinol Laryngol; 1977; 86(1 Pt 1):9-11. PubMed ID: 835977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin ototoxicity.
    McGhan LJ; Merchant SN
    Otol Neurotol; 2003 Jul; 24(4):701-2. PubMed ID: 12851569
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia.
    Swanson DJ; Sung RJ; Fine MJ; Orloff JJ; Chu SY; Yu VL
    Am J Med; 1992 Jan; 92(1):61-8. PubMed ID: 1731511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin.
    Vasquez EM; Maddux MS; Sanchez J; Pollak R
    Arch Intern Med; 1993 Apr; 153(7):879-82. PubMed ID: 8466379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity of erythromycin lactobionate.
    Lornoy W; Steyaert J
    Acta Clin Belg; 1979; 34(2):111. PubMed ID: 314715
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT
    J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin ototoxicity: analysis and conclusions based on 22 case reports.
    Haydon RC; Thelin JW; Davis WE
    Otolaryngol Head Neck Surg; 1984 Dec; 92(6):678-84. PubMed ID: 6440087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin ototoxicity in liver transplant patients.
    Moral A; Navasa M; Rimola A; García-Valdecasas JC; Grande L; Visa J; Rodés J
    Transpl Int; 1994; 7(1):62-4. PubMed ID: 8117405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxic effect of erythromycin therapy.
    Schweitzer VG; Olson NR
    Arch Otolaryngol; 1984 Apr; 110(4):258-60. PubMed ID: 6704042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin ototoxicity.
    Thompson P; Wood RP; Bergstrom L
    J Otolaryngol; 1980 Feb; 9(1):60-2. PubMed ID: 7359612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hearing loss after erythromycin therapy].
    Lind O; Harthug S
    Tidsskr Nor Laegeforen; 1993 Sep; 113(22):2810-1. PubMed ID: 8211901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity of erythromycin in patients with renal insufficiency.
    Méry JP; Kanfer A
    N Engl J Med; 1979 Oct; 301(17):944. PubMed ID: 481548
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensorineural hearing loss with low dose erythromycin.
    Kemp E; Keidar S; Brook JG
    BMJ; 1991 Jun; 302(6788):1341. PubMed ID: 2059706
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythromycin-induced hypoacusis: 11 new cases and literature review.
    Sacristán JA; Soto JA; de Cos MA
    Ann Pharmacother; 1993; 27(7-8):950-5. PubMed ID: 8364281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin-induced ototoxicity.
    Méry JP; Kanfer A
    Mayo Clin Proc; 1983 Jun; 58(6):401. PubMed ID: 6855278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ototoxic potential of erythromycin].
    Demaldent JE; Rolland A; Mongrolle Y
    Ann Otolaryngol Chir Cervicofac; 1984; 101(8):643-7. PubMed ID: 6534259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of the ototoxicity of cisplatin].
    Basterra J; Iranzo C; Marco J
    An Otorrinolaringol Ibero Am; 1985; 12(2):167-72. PubMed ID: 4039901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.